Y64N (p.Tyr64Asn) variant of SLC40A1 (Ferroportin)

Y64N (p.Tyr64Asn) in SLC40A1 (Ferroportin) is a missense change. Clinical records from EBI and UniProt describe it as pathogenic in the context of in HFE4. The available variant effect predictions contribute to a CATVariant prioritization score of 0.62 / 1. The record also includes published literature and structural context.

Y64N (p.Tyr64Asn) variant details